medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2018, Number 2

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2018; 16 (2)

Aggressive Basal Cell Carcinoma

Alcalá PD, Carmona CFP, González GJF

Language: Spanish
References: 13
Page: 134-137
PDF size: 146.60 Kb.


ABSTRACT

Basal cell carcinoma is the most common malignant tumor of the skin, generally is very slow-growing, minimal soft tissue invasiveness, a high cure rate and doesn’t usually compromise a vital risk because it has an extremely low metastatic potential, estimated at 0.0028 to 0.5%. However, there are cases in which their local aggressiveness is very important, and it get to destroy deep structures in a short period of time.
The purpose of this article is to describe the molecular, clinical, evolutionary and histological features present in an aggressive basal cell carcinoma and metastatic basal cell carcinoma.


REFERENCES

  1. Verkouteren J, Smedinga H, Steyerberg E, Hofman A y Nijsten T, Predicting the risk of a second basal cell carcinoma, Journal of Investigative Dermatology 2015; 135:2649-56.

  2. Walling H, Fosko S, Geraminejad P, Whitaker D y Arpey C, Aggressive basal cell carcinoma: presentation, pathogenesis, and management, Cancer and Metastasis Reviews 2004; 23:389-402.

  3. Lewin J y Carucci J, Management of aggressive basal cell carcinoma, Curr Derm Rep 2015; 4:213-20.

  4. Lohuis P, Joshi A, Borggreven P, Vermeeren L, Zupan B, Al A et al., Aggressive basal cell carcinoma of the head and neck: challenges in surgical management, Eur Arch Otorhinolaryngol 2016; 273:3881-89.

  5. Lupu M, Caruntu C, Ghita M, Voiculescu V, Voiculescu S y Rosca A, Gene expression and proteome analysis as sources of biomarkers in basal cell carcinoma, Disease Markers 2016; 1-9.

  6. Saucedo A, Gutiérrez R y Medina A, Cáncer de piel en el Centro Dermatológico Pascua. Estudio epidemiológico de 10 años, Dermatología Rev Mex 2005; 49:231-9.

  7. Hernández S, Medina A, López A y Alcalá D, Epidemiología del cáncer de piel en pacientes de la Clínica de Dermato-oncología del Centro Dermatológico Dr. Ladislao de la Pascua. Estudio retrospectivo de los últimos ocho años, Dermatol Rev Mex 2012; 56(1):30-7.

  8. McCusker M, Basset N, Dummer R, Lewis K, Schadendorf D, Sekulic A et al., Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of the disease, European Journal of Cancer 2014; 50:774-83.

  9. Tang S, Thompson S y Smee R, Metastatic basal cell carcinoma: case series and review of the literature, Australasian Journal of Dermatology 2016; 1-4.

  10. Mulvaney P, Higgins W, Dufresne R, Cruz A y Lee K, Basal cell carcinoma of the ear are more aggressive than on other head and neck locations, J Am Acad Dermatol 2014; 70(5):924-6.

  11. Bucci T, Santoro A, Pannone G, Rodríguez J, Fior A y Francesco P, Metastasic basosquamous carcinoma: report of two cases and clinicopathological considerations, International Journal of Surgical Pathology 2016; 24(8):726-32.

  12. Vega M. y Granados M, Atlas de dermatooncología. Carcinoma basocelular, capítulo 4, 2015; 13-18.

  13. Torres V, Camacho F, Mihm M. Dermatología práctica Ibero-Latinoamericana. 2a ed. México: Encuentros Científicos Académicos S.C., 2012.




2020     |     www.medigraphic.com